A monthly column on biotech for founders and builders in Central and Eastern Europe. The first asks why cheaper design hasn't ...
Jan Buza is a partner at ZAKA, an early-stage fund focused on health and industrial technology. He has invested for almost ten years and built two companies in regulated industries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results